Orexo announces new US patent for ZUBSOLV® |
| December 30, 2020 | December 2020 Bond Updates |
|
UPPSALA, Sweden, Dec. 30, 2020 /PRNewswire/ -- Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY) today announces that the US Patent and Trademark Office has issued an additional patent for ZUBSOLV®, Orexo's sublingual buprenorphine and naloxone tablet (CII) for the treatment of opioid use... |
| View more at: https://www.prnewswire.com:443/news-releases/orexo-announces-new-us-patent-for-zubsolv-301199255.html |
| Related News |
|